Global research trends in immunotherapy for head and neck neoplasms: A scientometric study

被引:4
作者
Jiang, Zhou [1 ]
Wu, Chenzhou [1 ]
Zhao, Yiming [1 ]
Zhan, Qi [1 ]
Wang, Kunyu [1 ]
Li, Yi [1 ,2 ]
机构
[1] Sichuan Univ, West China Hosp Stomatol, Natl Clin Res Ctr Oral Dis, Dept Head & Neck Oncol,State Key Lab Oral Dis, Chengdu 610041, Sichuan, Peoples R China
[2] Sichuan Univ, West China Hosp Stomatol, Dept Head & Neck Oncol, 14,3rd Sect Renminnan Ave, Chengdu 610041, Sichuan, Peoples R China
基金
中国国家自然科学基金;
关键词
Scientometric; Immunotherapy; Head and neck neoplasms; Head and neck squamous cell carcinoma; Nivolumab; PD-1; SQUAMOUS-CELL CARCINOMA; RADIOTHERAPY; RECURRENT; CANCER; COCITATION; NIVOLUMAB; ANTIBODY; IMMUNITY; SCIENCE; SAFETY;
D O I
10.1016/j.heliyon.2023.e15309
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
In recent decades, the traditional treatment of head and neck neoplasms has reached a bottleneck with limited improvement in overall survival. Nevertheless, the emerging field of immunotherapy has shown promise. Literature on research into immunotherapy for head and neck neoplasms was retrieved from WoSCC. Citespace was used as a scientometric analysis tool for text mining and visualization of the scientific literature. This analysis included 1915 documents. Recently, the annual number of publications and citations has been growing rapidly. 'Oncology' was the most popular research area. The most dominant institution and country were the University of Pitts-burgh and the USA. Ferris RL was not only the most prolific but also the most cited author, demonstrating a strong influence and reputation. Of the ten core journals identified in this field, Cancer Research ranked first. 'Regulatory T cell', 'PD-1' and 'biomarker' were regarded as current hotspots, while 'recurrent' and 'nivolumab' were considered as trending keywords. The most cited reference was Ferris RL (2016). Notably, the front trends and future directions in the field may lie in the clinical practice of combination therapy of immunotherapy plus other therapies, the mechanism of impaired immune surveillance, and the improvement in resistance to immu-notherapeutic agents. It is firmly believed that the present scientometric analysis has provided both a macroscopic and microscopic overview of research into immunotherapy for head and neck neoplasms, which will assist researchers and oncologists to better understand this discipline and thus promote further development and policies in this field.
引用
收藏
页数:10
相关论文
共 59 条
[1]   Radiation therapy in head and neck cancer [J].
Alfouzan, Afnan F. .
SAUDI MEDICAL JOURNAL, 2021, 42 (03) :247-254
[2]   The clinical implications of antitumor immunity in head and neck cancer [J].
Allen, Clint T. ;
Judd, Nancy P. ;
Bui, Jack D. ;
Uppaluri, Ravindra .
LARYNGOSCOPE, 2012, 122 (01) :144-157
[3]   Increased lymphocyte infiltration in patients with head and neck cancer treated with the IRX-2 immunotherapy regimen [J].
Berinstein, Neil L. ;
Wolf, Gregory T. ;
Naylor, Paul H. ;
Baltzer, Lorraine ;
Egan, James E. ;
Brandwein, Harvey J. ;
Whiteside, Theresa L. ;
Goldstein, Lynn C. ;
El-Naggar, Adel ;
Badoual, Cecile ;
Fridman, Wolf-Herve ;
White, J. Michael ;
Hadden, John W. .
CANCER IMMUNOLOGY IMMUNOTHERAPY, 2012, 61 (06) :771-782
[4]   Trial watch: Naked and vectored DNA-based anticancer vaccines [J].
Bloy, Norma ;
Buque, Aitziber ;
Aranda, Fernando ;
Castoldi, Francesca ;
Eggermont, Alexander ;
Cremer, Isabelle ;
Sautes-Fridman, Catherine ;
Fucikova, Jitka ;
Galon, Jerome ;
Spisek, Radek ;
Tartour, Eric ;
Zitvogel, Laurence ;
Kroemer, Guido ;
Galluzzi, Lorenzo .
ONCOIMMUNOLOGY, 2015, 4 (05)
[5]  
Böttcher A, 2013, CANCER GENOM PROTEOM, V10, P197
[6]   Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck [J].
Bonner, JA ;
Harari, PM ;
Giralt, J ;
Azarnia, N ;
Shin, DM ;
Cohen, RB ;
Jones, CU ;
Sur, R ;
Raben, D ;
Jassem, J ;
Ove, R ;
Kies, MS ;
Baselga, J ;
Youssoufian, H ;
Amellal, N ;
Rowinsky, EK ;
Ang, KK .
NEW ENGLAND JOURNAL OF MEDICINE, 2006, 354 (06) :567-578
[7]   Immunotherapy Breakthroughs in the Treatment of Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma [J].
Borel, Christian ;
Jung, Alain C. ;
Burgy, Mickael .
CANCERS, 2020, 12 (09) :1-19
[8]  
BRAAM RR, 1991, J AM SOC INFORM SCI, V42, P252, DOI 10.1002/(SICI)1097-4571(199105)42:4<252::AID-ASI2>3.0.CO
[9]  
2-G
[10]   Safety and Activity of Anti-PD-L1 Antibody in Patients with Advanced Cancer [J].
Brahmer, Julie R. ;
Tykodi, Scott S. ;
Chow, Laura Q. M. ;
Hwu, Wen-Jen ;
Topalian, Suzanne L. ;
Hwu, Patrick ;
Drake, Charles G. ;
Camacho, Luis H. ;
Kauh, John ;
Odunsi, Kunle ;
Pitot, Henry C. ;
Hamid, Omid ;
Bhatia, Shailender ;
Martins, Renato ;
Eaton, Keith ;
Chen, Shuming ;
Salay, Theresa M. ;
Alaparthy, Suresh ;
Grosso, Joseph F. ;
Korman, Alan J. ;
Parker, Susan M. ;
Agrawal, Shruti ;
Goldberg, Stacie M. ;
Pardoll, Drew M. ;
Gupta, Ashok ;
Wigginton, Jon M. .
NEW ENGLAND JOURNAL OF MEDICINE, 2012, 366 (26) :2455-2465